Comparable viral decay with initial dolutegravir plus lamivudine versus dolutegravir-based triple therapy

OBJECTIVES: To expand understanding of the virological potency of initial dolutegravir plus lamivudine dual therapy (dolutegravir/lamivudine), we compared the viral decay seen in the pilot ACTG A5353 study with the decay observed with dolutegravir plus two NRTIs in the SPRING-1 and SINGLE studies, w...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Antimicrob Chemother
Main Authors: Gillman, Jason, Janulis, Patrick, Gulick, Roy, Wallis, Carole L, Berzins, Baiba, Bedimo, Roger, Smith, Kimberly, Aboud, Michael, Taiwo, Babafemi
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6640296/
https://ncbi.nlm.nih.gov/pubmed/31039247
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkz190
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados